4//SEC Filing
Gelder Mark S. MD 4
Accession 0001415889-22-008260
CIK 0001130598other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:34 PM ET
Size
8.6 KB
Accession
0001415889-22-008260
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-02+4,650→ 7,031 total - Tax Payment
Common Stock
2022-08-03$1.32/sh−1,135$1,498→ 5,896 total - Exercise/Conversion
Restricted Stock Units
2022-08-02−4,650→ 9,300 total→ Common Stock (4,650 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001564390
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:34 PM ET
- Size
- 8.6 KB